期刊文献+

急性冠状动脉综合征患者血清基质金属蛋白酶-9检测的临床价值

下载PDF
导出
摘要 急性冠状动脉综合征(acute coronary syndrome,ACS)是一种严重威胁人类生命健康的疾病,它分为不稳定型心绞痛(UA)和急性心肌梗死(AMI)。ACS患者冠状动脉造影结果提示,ACS的发生并不由粥样硬化斑块增大致血管腔堵塞导致,而是主要由于动脉粥样硬化斑块不稳定,在某些炎症因素的作用下发生破裂,继发血栓形成,出现完全或不完全性冠状动脉阻塞造成的^[1]。
出处 《实用医技杂志》 2012年第3期292-294,共3页 Journal of Practical Medical Techniques
  • 相关文献

参考文献8

  • 1Braunwald E,Elhott M,John W,et al.Guidelines for the man-agement of patient with unstable angina and non-ST-segment ele-vation myocardial infaction:excutive summary and recom-mend-meriation.Circulation,2000,102:1193-1209.
  • 2牛玉宏,许从峰,葛均波.炎症反应与动脉粥样硬化[J].北京大学学报(医学版),2001,33(4):323-327. 被引量:8
  • 3Natale DB,Rossella T,Michele C,et al.C-reactive protein in patients with acute coronany syndname:correlation with diagno-sis,myocardial damage,ejection fraction and angiographic fin-ding.Int J Cardiol,2006,109(2):248-256.
  • 4Morishgo K,Shimokawa H,Matsumoto Y,et al.Over expression of matrix metalloproteinase-9 promotes intravascular thrombus for-mation in porcine coronary arteries in vivo.Cardiovasc Res,2003,57(2):572-585.
  • 5Loftus M,Naylor AR,Goodall S,et al.Increased matrix metal-loproteinases-9 activity in unstable carotid plaque:a protential role on acute plaque disruption.Stroke,2003,30(1):40-47.
  • 6Blankenberg S,Rupprecht HJ,Poirier O,et al.Plasma concentrations and genetic variation metalloproteinase-9 and prognosis ofpatients with cardiovascular disease.Circulation,2003,107 (12):1579-1585.
  • 7Manginas A,Bei E,Chaidaroglou A,et al.Peripheral levels of matrix metalloproteinase-9,interleukin-6,and C-reactive protein are elevated in patients with acute coronary syndromes:correla-tions with serum troponin Ⅰ.Clin Cardiol,2005,28(4):182-186.
  • 8李彬,何家富,刘文卫,江华,沈青山,朱锐,陶红,赵玉勤.不同类型冠心病患者血浆脑钠肽、基质金属蛋白酶及其抑制物、超敏C反应蛋白水平的变化[J].临床心血管病杂志,2009,25(11):827-829. 被引量:16

二级参考文献14

  • 1SUZUKI T, YAMAZAKI T, YAZAKI Y, et al. The role of the natriuretic peptide in the cardiovascular system[J]. Cardiovasc Res, 2001, 51: 489-494.
  • 2OLLIVIER J P, REVEL F. Brain natriuretic peptide in acute coronary syndromes: utility of NT-pro BNP assay[J]. Bull Acad Natl Med, 2004, 188:1529 - 1538.
  • 3NDREPEPA G, BRAUN S, MEHILLI J, et al. Plasma levels of N-terminal pro-brain natriuretie peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction[J]. Am J Cardiol, 2005, 95:553-557.
  • 4IKEDA U, SHIMADA K, Matrix metalloproteinses and coronary artery diseases [J]. Clin Cardiol, 2003, 26:55-55.
  • 5BLAKE G J, RIDKER P M. Inflammatory bio-markers and cardiovascular risk prediction[J]. Intern Med, 2002,252: 283-294.
  • 6RIDKER P M. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk:moving an inflammatory hypothesis toward consensus[J]. J Am Coll Cardiol, 2007,49:2129-2138.
  • 7BEAUDEUX J L, GIRAL P, BRUCKERT E, et al. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives[J]. Clin Chem Lab Med, 2004, 42: 121-131.
  • 8SIWIK D A, COLUCCI W S. Regulation of matrix metalloproteinases by cytokines and reactive oxygen/ nitrogen species in the myocardium[J]. Heart Fail Rev, 2004,9: 43-43.
  • 9TSURUDA T, BOERRIGTER G, HUNTLEY B K, et al. Brain natriuretic peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases[J]. Circ Res, 2002 , 91:1127-1134.
  • 10KAWAKAMI R, SAITO Y, KISHIMOTO I, et al. Overexpression of brain natriuretic peptide facilitates neutrophil infiltration and cardiac matrix metalloproteinase-9 expression after acute myocardial infarction [J]. Circulation,2004 ,110:3306-3312.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部